BioLineRx Ltd. Profit Loss Attributable To Noncontrolling Interests
BioLineRx Ltd. (BLRX) reported Profit Loss Attributable To Noncontrolling Interests of $6.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Notes
ifrs-full:ProfitLossAttributableToNoncontrollingInterests · last filed 2026-03-23
| Period end | Profit Loss Attributable To Noncontrolling Interests 12 month |
|---|---|
| 2025-12-31 | $6.00M 20-F · filed 2026-03-23 |